Dongwook Lee

Dongwook Lee

Auto-generated profile, based on publicly available information

Dongwook Lee

Department of Life Sciences, POSTECH Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang 37673, Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Immune Network
Verified
Journal Article
Open access
PDF file
DLDongwook Lee
Dongwook Lee
YLYoontae Lee
Yoontae Lee
Lee D, et al. Immune Netw. 2026 Feb;26(1):e5. https://doi.org/10.4110/in.2026.26.e5

4 October 2025 in bioRxiv
Verified
Preprint
Open access
DLDongwook Lee
Dongwook Lee
YKYewon Kim
Yewon Kim
HGHyeonMin Gil
HyeonMin Gil
JLJiyun Lee
Jiyun Lee
YCYoon Ha Choi
Yoon Ha Choi
YLYoontae Lee
Yoontae Lee
Exhausted CD8 + T (Tex) cells comprise heterogeneous subsets with varying cytotoxic and dysfunctional properties, making inhibitory receptor profiles unreliable indicators of function. Therefore, it is essential to define transcriptional regulators or markers that accurately reflect these states. Here, we identified ETS variant 4 (ETV4) as a transcription factor that restricts cytotoxic Tex differentiation within tumors. ETV4 deficiency promotes the emergence of a CD74 + cytotoxic Tex subset while preserving the progenitor Tex (Tpex) pool. CD74 serves as both a marker and regulator, reinforcing Tpex features and enhancing Tex cytotoxicity. Mechanistically, ETV4 loss derepresses T-bet expression, thereby increasing IFNγ production that induces CD74 expression in a paracrine manner. Single-cell analyses across human cancers revealed that CD74 + Tex cells are enriched for proliferative and metabolic programs and correlate with improved survival. Collectively, we establish the ETV4–CD74 axis as a regulator of Tex fate and promising therapeutic target to augment anti-tumor immunity.